(VIANEWS) – TOUR EIFFEL (EIFF.PA), GALIMMO (GALIM.PA), IMMO MOURY (IMMOU.BR) are the highest payout ratio stocks on this list.
We have gathered information regarding stocks with the highest payout ratio so far. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. TOUR EIFFEL (EIFF.PA)
625% Payout Ratio
Société de la Tour Eiffel is an integrated property company with EUR 1.8 bn in assets and a powerful service culture. This agile company operates in various asset classes, including offices, urban logistics, managed residential and retail, in Greater Paris and other major French metropolitan areas. An active player throughout the property cycle, it assists its tenants – companies of all sizes and sectors – through high-standard direct management of its properties. Société de la Tour Eiffel conducts a pro-active and transversal CSR policy that is an integral part of its strategic orientations. Société de la Tour Eiffel is listed on Euronext Paris (B board) – ISIN code: FR0000036816 – Reuters: TEIF.PA – Bloomberg: EIFF.FP – Member of the IEIF Foncières and IEIF Immobilier France indices.
Earnings Per Share
As for profitability, TOUR EIFFEL has a trailing twelve months EPS of €-0.65.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.54%.
More news about TOUR EIFFEL.
2. GALIMMO (GALIM.PA)
124.14% Payout Ratio
Galimmo SCA operates as a real estate company in Europe. As of December 31, 2021, it owned and managed 52 shopping malls. Galimmo SCA was formerly known as C&Co SCA and changed its name to Galimmo SCA in September 2016. The company was incorporated in 1902 and is headquartered in Paris, France. Galimmo SCA is a subsidiary of Galimmo Real Estate.
Earnings Per Share
As for profitability, GALIMMO has a trailing twelve months EPS of €0.29.
PE Ratio
GALIMMO has a trailing twelve months price to earnings ratio of 52.41. Meaning, the purchaser of the share is investing €52.41 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.01%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 0.36 and the estimated forward annual dividend yield is 2.35%.
Yearly Top and Bottom Value
GALIMMO’s stock is valued at €15.20 at 01:10 EST, under its 52-week high of €15.60 and way higher than its 52-week low of €12.90.
Moving Average
GALIMMO’s worth is above its 50-day moving average of €15.18 and above its 200-day moving average of €14.76.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1%, now sitting on 46.39M for the twelve trailing months.
More news about GALIMMO.
3. IMMO MOURY (IMMOU.BR)
71.43% Payout Ratio
Immo Moury SCA is a real estate investment trust. Immo Moury SCA is based in Belgium.
Earnings Per Share
As for profitability, IMMO MOURY has a trailing twelve months EPS of €2.52.
PE Ratio
IMMO MOURY has a trailing twelve months price to earnings ratio of 13.65. Meaning, the purchaser of the share is investing €13.65 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.04%.
Yearly Top and Bottom Value
IMMO MOURY’s stock is valued at €34.40 at 01:10 EST, way under its 52-week high of €41.00 and above its 52-week low of €31.60.
Revenue Growth
Year-on-year quarterly revenue growth grew by 55.3%, now sitting on 2.93M for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Oct 13, 2023, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 5.14%.
More news about IMMO MOURY.
4. SANOFI (SAN.PA)
49.31% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €7.22.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 12.31. Meaning, the purchaser of the share is investing €12.31 for every euro of annual earnings.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 30, 2023, the estimated forward annual dividend rate is 3.56 and the estimated forward annual dividend yield is 4.06%.
More news about SANOFI.
5. UMICORE (UMI.BR)
39.6% Payout Ratio
Umicore SA operates as a materials technology and recycling company worldwide. It operates through Catalysis, Energy & Surface Technologies, and Recycling segments. The Catalysis segment produces automotive catalysts for gasoline, and diesel light and heavy-duty diesel applications; stationary catalysis for industrial emissions control; and precious metals-based compounds and catalysts for use in the pharmaceutical and fine chemicals industries, as well as fuel cell applications. The Energy & Surface Technologies segment offers cobalt and specialty materials, rechargeable battery materials, and electro-optic materials, as well as metal deposition solutions, including electroplating and PVD coating. The Recycling segment treats waste streams containing precious and other specialty metals from a range of industrial residues and end-of-life materials. This segment also produces precious metals-based materials for glass production, electric, and electronic applications. The company was formerly known as Union Minière du Haut Katanga and changed its name to Umicore SA in 2001. Umicore SA was founded in 1805 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UMICORE has a trailing twelve months EPS of €2.02.
PE Ratio
UMICORE has a trailing twelve months price to earnings ratio of 12.12. Meaning, the purchaser of the share is investing €12.12 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.58%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 18, 2023, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 3.27%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 22.3%, now sitting on 22.57B for the twelve trailing months.
More news about UMICORE.
6. SOLVAY (SOLB.BR)
39.59% Payout Ratio
Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aerospace, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, phenols and derivatives, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the food, flavors, and fragrances industries, as well as value-added intermediates used in monomers and polymers, pharmaceuticals, agrochemicals, and electronics. This segment also provides various products for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications; and PROBAN, a technological process that offers durable flame retardant properties to cotton-based textiles. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, SOLVAY has a trailing twelve months EPS of €10.23.
PE Ratio
SOLVAY has a trailing twelve months price to earnings ratio of 2.54. Meaning, the purchaser of the share is investing €2.54 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.93%.
More news about SOLVAY.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
More news about 1.
